Cizzle Brands (8YF.F) traded flat 0 % during a 24 hours period ending at 10:46 PM Central Europe on Tuesday 27th. One Cizzle Brands stock can currently be bought for about CAD 0.34 on popular exchanges. Current supply of Cizzle Brands stocks is 230.3 mn. Cizzle Brands has a current market capitalization of CAD 78.3 mn and approximately CAD 1.9 k worth of Cizzle Brands was traded on exchanges in the last 24 hours. Since last month end, Cizzle Brands has traded -10.53 % down. Simple moving average of last 200 days is at CAD 0.34. The highest price of past 52 weeks was recorded at CAD 0.51 on 07/31/2026. 52 weeks low was at CAD 0.26 on 07/28/2026.
Summary of the latest news for Cizzle Brands
Cizzle Brands Corporation announced that its board has approved a 1‑for‑25 share consolidation to meet the minimum price requirement for a proposed listing of its common shares on a U.S. national securities exchange. The consolidation is expected to take effect on October 29, 2026, after regulatory approval from Cboe Canada. Following the consolidation, the shares will trade on the Cboe platform under the existing ticker symbol. The company stated that aligning its share structure with U.S. exchange standards is intended to increase liquidity, attract institutional capital and support long‑term equity value. The consolidation will automatically exchange registered shareholders’ pre‑consolidation shares for post‑consolidation shares, with no action required from holders. The move is part of a broader capital‑markets expansion strategy that includes a planned U.S. public offering of common shares.
Here is how related stocks have performed in the past 24 hours:
Infrastructure Sp (IS.TO) traded up 0.32 % and now trades at CAD 19.05. Infrastructure Sp has a market capitalisation of CAD 92.8 mn.
Haivision (HAI.TO) traded down -0.29 % and now trades at CAD 3.61. Current market capitalisation for Haivision is CAD 92.1 mn.
Oncolytics Biotech (ONCY) traded down -6 % and now trades at USD 0.46. Oncolytics Biotech has a market capitalisation of USD 65 mn. Oncolytics Biotech Inc. has announced the commencement of its first randomized clinical trial data for a colorectal cancer therapy. The company stated that the data release will provide insight into the treatment’s efficacy and safety profile, supporting its development pipeline. No financial performance figures or market expectations were disclosed in the announcement. The company’s focus remains on advancing its clinical programs, with the upcoming data expected to inform future investment and partnership discussions.
Argo (ARGH.V) traded flat 0 % and now trades at CAD 0.3. Current market capitalisation for Argo is CAD 93.1 mn.
Awale (ARIC.V) traded down -1.56 % and now trades at CAD 0.69. Awale has a market capitalisation of CAD 90.4 mn.